SPONSORS
EHMSG gratefully acknowledges the support of the following companies and institutions
RICHEN EUROPE is the European operating branch of the RICHEN GROUP, a major international group of medical device manufacturers with a global commitment. The company specializes in developing the best solutions for patients in the field of gastroenterology. Over the years our R&D department has excelled in the design and development of high-performance safe equipment and reagents for the diagnosis of Helicobacter pylori infection. Since 2015, the Richen Group has been supporting the European Helicobacter & Microbiota Study Group (EHMSG) as Platinum Sponsor.
INFAI is specialized in the transfer of advanced analytical technology in the field of medical diagnostics and the development of innovative pharmaceutical products. The company is a pioneer in the use of stable isotopes in gastroenterology, cardiovascular and inborn metabolic diseases. Helicobacter Test INFAI (HTI) is approved in centralized procedure by EMA first time in all European countries since 1997 and available for routine diagnosis of Helicobacter pylori infection. Until now more than 7.5 Mio HTI performed worldwide. In the meantime, HTI is registered as medicinal product (medical prescription) in more than 40 countries worldwide.
INFAI's laboratories in Bochum, Germany and in York, England are equipped with state-of-the-art IRMS mass spectrometer and 600 MHz NMR spectrometer which is used to investigate metabolic disorders, cardiovascular diseases and a number of other diseases. These facilities are used for internal research and product development, but are also available for collaborative and contract research. In last 10 years, a range of non-invasive, highly efficient breath tests using stable isotopes has been developed. REFEX (for patients taking PPI’s or patients with atrophic gastritis), Gastromotal (13C octanoic acid gastric emptying test) and Pancreo-Lip (13C mixed triglyceride exocrine pancreatic function test) are in preparation for approval by EMA but now available for clinical studies. INFAI is associated with a number of companies in several European countries and outside the Europe. All other developed products of INFAI you can find on our website: www.infai1.com.
Since 1997, INFAI GmbH has been supporting the European Helicobacter & Microbiota Study Group (EHMSG) as Gold Sponsor.
SPONSORS & EXHIBITORS EHMSG 2025
GOLD SPONSORS
Aboca is an Italian company that develops 100% natural and biodegradable products for human health. It produces medical devices and supplements based on complex natural substances, relying on medical-scientific evidence and One Health criteria. The organic and sustainable supply chain excludes artificial substances and GMOs, and it distributes directly with continuous training for doctors and pharmacists. Additionally, as a certified B Corp Benefit Corporation, Aboca operates responsibly, sustainably, and transparently for the benefit of the community and the environment.
Alfasigma is a global pharmaceutical company founded over 75 years ago in Italy, where it is headquartered (in Bologna and Milan). The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. It has offices in many countries, including Italy, the US, Spain, Germany, Mexico, and China; production sites in Italy (Pomezia, RM; Alanno, PE; Sermoneta, LT; Trezzano Rosa, MI), Spain (Tortosa, Baix Ebre), and the United States (Shreveport, Louisiana); and R&D labs in Italy (Pomezia and Bergamo). Alfasigma employs approximately 4,000 people dedicated to research, development, production, and distribution of medicinal products, contributing to its mission to provide better health and a better quality of life for patients, caregivers, and healthcare providers. It focuses on three main therapeutic areas: Gastroenterology, Vascular, and Rheumatology. Its portfolio spans from primary care to specialty care, rare disease medications, and consumer health products, including medical foods and nutraceuticals.
Malesci (https://www.malesci.it/en-us/), a historic Italian pharmaceutical company founded in Florence in 1850, celebrates its 175th anniversary in 2025. The company is dedicated to research, pharmaceutical production, and scientific information, with the mission to promote health and improve people's quality of life, placing patient well-being at the center of its activities.
Started as a "Drugstore and Pharmacy" by Pietro Malesci, the company transformed into a "Pharmaceutical Laboratory" in 1896 under the guidance of his son, Carlo Malesci. Since 1978, Malesci has been part of the Menarini Group, expanding its portfolio with high-profile molecules in various therapeutic areas; the main cardiovascular and gastrointestinal.
SILVER SPONSORS
Coree Srl is an Italian company, specialized in R&D of food supplements, pharmaceutical products and medical devices.
Founded in 2016, the company has always been focused on the development of probiotics and innovative products.
Thanks to the international collaboration with pharmaceutical partners, like Hanmi Pharmaceutical, CoreeGroup and Dx&Vx Ltd, Coree is born with a strong orientation for R&D, creating an important network with main KOL and national prestigious scientific institutions.
Named Group | Wellmicro
Nasce nel 2015 come spin-off dell’Università di Bologna e attualmente fa parte di NAMED GROUP. Prima e unica azienda dedicata esclusivamente all’analisi del microbioma, Wellmicro utilizza tecnologia di sequenziamento genetico di ultima generazione (Next Generation Sequencing, NGS) e ha elaborato metodi di interpretazione dei dati e database proprietari, definendo protocolli affidabili in ogni fase di lavorazione. Nel 2016 ha lanciato sul mercato il primo test sul microbiota intestinale e nel 2023 il Vaginal test, entrambi con metodologia brevettata. Dal 2024 Wellmicro eleva ulteriormente gli standard di analisi dei suoi test con il passaggio alla metagenomica di tipo “shotgun” che consente di sequenziare simultaneamente tutto il DNA di tutti i microrganismi (batteri, virus, miceti e parassiti) presenti nel campione, ottenendo una fotografia sia tassonomica che funzionale dell’ecosistema microbico della massima risoluzione possibile.
BRONZE SPONSORS
Dicofarm, a pharmaceutical company founded in 1977, has always been attentive to the needs of infants and children.
Our products are the result of continuous research aimed at developing innovative solutions for the care and nutrition of consumers, thanks also to constant collaboration with the medical community, which keeps us updated on their needs.
From Dicofarm's experience, AG Pharma was founded in 2002 to offer its know-how to adult medicine in various therapeutic areas. A few years later, the Dicofarm group was ready to begin the process of internationalization by entering the Polish market. In 2006, Dicofarm Polska (ex Vitis Pharma) was established, a company that is now a leader in nutraceuticals in Poland. In 2025, two more branches were opened, in Spain (Dicofarm Spain) and Romania (Dicofarm Romania)
After more than 40 years of success, Dicofarm is now present in many countries worldwide.
Zambon is a multinational pharmaceutical company established in 1906 in Vicenza, whose history is founded on the values of an Italian family committed to innovating cure & care to improve patients’ lives. It employs more than 2,500 people worldwide, it is present in 23 countries. Alongside the three historical therapeutic areas - diseases of the respiratory system, urinary tract infections and pain treatment – Zambon is focused on developing treatments for neurodegenerative diseases such as Parkinson's and ALS.
EXHIBITORS
Institut AllergoSan, led for over 30 years by Prof. Anita Frauwallner and based in Graz, Austria, is an internationally recognized center of excellence in microbiome research. Institut AllergoSan is especially known for its wide range of high-quality OMNi-BiOTiC® probiotics, which are scientifically tested and supported by clinical studies. OMNi-BiOTiC® is available in 40 countries and is the number one probiotic brand in Austria, Germany, and Switzerland, as well as the third worldwide.
Biocodex, a French independent family-owned pharmaceutical group founded in 1953, is committed to improving patients’ health and well- being at every stage of life, focusing on three pillars: microbiota care, women’s health, and orphan diseases. Biocodex particularly markets the probiotic strain Saccharomyces boulardii CNCM I-745, a pioneer in the probiotics category and currently the world’s #1 by value. www.biocodex.com
Cadigroup is an Italian company based in Rome, established in 1993 by the passion and experience of Dr. Gianfranco Caramelli. His enduring goal has been to enhance health and well-being by harnessing the power of nature, creating customized products that reflect the company’s expertise and skills. As of today, Cadigroup is a point of reference in the field of gastroenterology with a wide range of nutraceutical products and, in particular, with the unique product Escherichia Coli Nissle 1917 directly imported from a German partner. Since 2020, Cadigroup enlarged its offer for patients by purchasing its first drug becoming a pharmaceutical company and consolidating its product’s portfolio in the IBD-gastro sector.
GenoScreen is a biotech company specialized in molecular microbiology. Alongside expert analytical services, our company develop molecular diagnostic tools to explore and exploit the properties of microbiotas, for research or innovation purposes for the benefit of the health, agri-food and environment. Our solutions are used in more than 80 countries worldwide in academia, industry, hospital, pharmaceutical institutions. Among them, “Deeplex HelP,” is a culture-free targeted-based deep sequencing assay, for identification, virulence and antibiotic resistance prediction of Helicobacter pylori.
Juvisé Pharmaceuticals is a family-owned pharmaceutical company whose mission is to prioritize essential medicines and improve the health of millions of people around the world: approximately 2.5 million patients are treated with our medicines each year. Since our creation in 2008, our portfolio has been built up through the acquisition of princeps drugs from leading pharmaceutical companies. Today, it includes 10 medications and covers 4 main therapeutic areas: neuroscience, gastroenterology, oncology and cardiology. Juvisé Pharmaceuticals is an international company with a strong European focus. The majority of our medicines are manufactured in Europe (87% in 2024, with an ambitious target of close to 100% by the end of 2025), and marketed in nearly 80 countries worldwide.
Mayoly Diagnostics aims to become a world leader in diagnostics and eradication control of Helicobacter pylori infections. We are offering innovative and trusted in vitro diagnostic solutions based on 13C Urea Breath Tests (non-radioactive) and 14C Urea Breath Tests (low radioactivity) for clinicians, pharmacies, laboratories and patients.
We today have customers in more than 50 countries and now yearn for expanding in new international countries.
Meridian Bioscience has been a trusted provider of diagnostic solutions for over 40 years, enhancing early diagnosis and effective patient care. As a pioneer in H. pylori testing, Meridian offers a comprehensive range of non-invasive tests, including Curian® HpSA® and BreathID® UBT, all aligned with clinical guidelines. We focus on speed, accuracy, and simplicity to meet diverse diagnostic needs—from physician offices to healthcare systems—empowering healthcare professionals with reliable solutions for gastrointestinal and respiratory infections, including pediatric testing.
.png)
For over 40 years, Metagenics® has been a trusted leader in premium micronutrition, committed to helping people live healthier, happier lives.
Through continuous investment in scientific research and advanced technologies, Metagenics® creates formulations that work in harmony with the body’s natural biochemical processes.
Each product is thoughtfully designed to ensure nutrients are easily absorbed and well tolerated, supporting overall health and well-being.
Metagenics® products are carefully developed using top-quality ingredients and optimal dosages to ensure the best possible results
Founded in Turin in 2014, NanoTech Analysis began as an innovative startup in MEMS and NEMS technologies, quickly evolving into a leading player in advanced instrumentation. Since 2017, as part of Laserline, the company has accelerated its growth and strategic development. With 64 patents and multiple European awards, NTA stands at the forefront of innovation, designing cutting-edge analytical devices. Its mission is to develop a new generation of high-performance analytical instruments, tackling challenges through a completely innovative approach.
GRANTS
EHMSG gratefully acknowledges a grant from the UEG
United European Gastroenterology (UEG) is Europe’s home and umbrella for multidisciplinary gastroenterology and unites over 50,000 engaged professionals from national and specialist societies, individual digestive health experts, and related scientists from all fields and career stages. As the leading non-profit organisation for excellence in digestive health, UEG improves the prevention and care of digestive diseases in Europe through providing top tier education, supporting research, and advancing clinical standards. The myUEG Community enables digestive health professionals from across the globe to become myUEG Associates and thereby connect, network and benefit from a wide range of free resources and educational activities.
UEG Week 2025 – October 4 - 7
in Berlin and online
The multidisciplinary UEG Week and Postgraduate Teaching (PGT) are the premier venues for researchers from across the globe to present their latest findings.
Abstract submission. February 24 – April 25, 2025, 23:59 CEST.
More information: https://ueg.eu/week/programme/abstracts
Scientific programme: Top-tier multidisciplinary science awaits! In every session, delegates have the opportunity to interact in real-time via our Q&A tool both in-person and virtually. Access the online programme here: https://ueg.eu/week/programme
Attractive registration packages to participate onsite in Vienna or online: https://ueg.eu/week/attendance
Join the multidisciplinary and multinational myUEG community in Berlin or online!
myUEG Community – Become a myUEG Associate and strengthen your digestive health network!
Our myUEG Community is your connection to an international and multidisciplinary digestive health community all-year-round. A plethora of outstanding free resources and educational activities await you. Become a myUEG Associate or myUEG Young GI Associate for free today! Grow a diverse digestive health network of friends, colleagues, peers and collaborators within the community via our exclusive, safe and secure My Connect networking platform.
Join us for free today: www.ueg.eu/myueg-community
Gutflix – GI learning, personalised
Visit UEG's new platform to access UEG Week recordings, posters, online courses, guidelines, Mistakes in... articles, podcast episodes and webinars. Our online library is evolving into Gutflix, your new interactive platform for gastroenterology content.
Log in, click on items that interest you, and Gutflix will learn what you like to provide personalised recommendations just for you.